Affimed Therapeutics B.V. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
34,649.50
343.50
22,443.40
35,637.30
34,089.60
22,978
Depreciation, Depletion & Amortization
566.90
585.00
372.60
408.20
395.90
475.40
Other Funds
24,517.10
17,253.10
634.30
3,585.20
5,238.10
2,212
Funds from Operations
9,565.50
17,011.70
21,436.50
31,643.90
28,455.50
20,289.30
Changes in Working Capital
2,027.30
3,021.60
882.70
3,894.90
362.10
78,613.80
Net Operating Cash Flow
7,538.20
13,990.00
20,553.80
35,538.80
28,817.60
58,324.50
Capital Expenditures
215.10
404.60
307.20
286.50
753.50
Sale of Fixed Assets & Businesses
6.60
9.30
-
-
39.50
Purchase/Sale of Investments
-
-
-
9,834.10
10,127.70
Net Investing Cash Flow
208.40
395.30
307.20
10,120.60
9,079.90
Issuance/Reduction of Debt, Net
6,749.60
9,310.30
-
267.70
2,619.10
Net Financing Cash Flow
6,749.60
59,542.80
59,325.00
261.10
26,841.50
Net Change in Cash
997.00
45,157.50
41,046.70
45,722.50
4,996.80
Free Cash Flow
7,722.80
14,334.90
20,830.00
35,802.10
29,522.60
Change in Capital Stock
-
50,232.50
59,325.00
6.60
24,222.40
Exchange Rate Effect
-
-
2,582.70
198.00
2,105.90
Other Uses
-
-
-
-
333.90
Miscellaneous Funds
-
-
-
-
1.10
About Affimed Therapeutics
View Profile
